We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
History of Pediatrics |

Making History Thomas Francis, Jr, MD, and the 1954 Salk Poliomyelitis Vaccine Field Trial

Sarah Marie Lambert, BA; Howard Markel, MD, PhD
Arch Pediatr Adolesc Med. 2000;154(5):512-517. doi:10.1001/archpedi.154.5.512.
Text Size: A A A
Published online


This article focuses on the poliomyelitis vaccine field trial directed by Thomas Francis, Jr, MD, of the University of Michigan Vaccine Evaluation Center and sponsored by the National Foundation for Infantile Paralysis (NFIP) or, as it was better known to the public, the March of Dimes. It was a landmark in the widescale testing of a vaccine and the ethical use of human subjects. Millions of American parents readily volunteered their healthy children to participate. A total of 150,000 volunteers, including schoolteachers, physicians, nurses, and health officers all endorsed the study and donated their time and effort to make it successful.1(p269) Avoiding the use of marginalized groups, the field trial purposefully did not involve institutionalized children; instead, it was based in 15,000 public schools in 44 of the 48 states as clinic sites.1(268) A group of 650,000 children received some type of injection, either the vaccine or a placebo, and another 1.18 million served as controls.2 The field trial depended, most essentially, on both public support and the participation of millions of children who remained enrolled in a study that required a series of 3 injections and a 6-month evaluation period. Enlisting the huge number of participants presented practical examples of the difficulties in experimenting on human subjects. On April 26, 1954, Randy Kerr, a participant or "Polio Pioneer" as the children involved were called, received the first inoculation of the Salk poliomyelitis vaccine. The nationwide study "designed to test the safety and efficacy"3(p177) of the Salk vaccine had officially begun.

Figures in this Article

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview


Place holder to copy figure label and caption
Figure 1.

Schoolchildren about to receive the Salk Poliomyelitis Vaccine, April 19, 1955. Used with permission from the March of Dimes Birth Defects Foundation, White Plains, NY.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

Announcement of the safety and efficacy of the Salk poliomyelitis vaccine, Rackham Auditorium, University of Michigan, Ann Arbor, April 12, 1955. Pictured left to right: Harlan Hatcher, PhD, president of the University of Michigan, Thomas Francis, Jr, MD, director of the Vaccine Field Trial, Jonas E. Salk, MD, developer of the vaccine, and Basil O'Connor, president of the National Foundation for Infantile Paralysis. Used with permission from the Michigan Historical Collections, Bentley Historical Library, University of Michigan, Ann Arbor.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

18 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles